chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I first developed a soft tissue knot on the arch of my left foot  about 4-5 days after my 1st injection which went away after 4 days then after my second injection I developed another knot on the arch of my left foot (same spot) this time it was hard and sore (painful to the touch) then over the next couple of weeks the knot swelled up and became more painful. I contacted my Doctor and reported and have been seeking care with him since as knot has decreased in size but still exist and still swells and painful from time to time.
This case was reported by a other health professional via call center representative and described the occurrence of pain in a 55-year-old female patient who received SHINGRIX (batch number 4G5HX, expiry date 9th July 2021) for prophylaxis. On 11th March 2019, the patient received SHINGRIX (intramuscular). On 11th March 2019, immediately after receiving SHINGRIX, the patient experienced pain, skin warm, inappropriate preparation of medication and inappropriate dose of vaccine administered. On 12th March 2019, the patient experienced erythema of extremities and induration. On an unknown date, the outcome of the pain, skin warm, erythema of extremities and induration were not recovered/not resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. It was unknown if the reporter considered the pain, skin warm, erythema of extremities and induration to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left deltoid. The patient had a red indurated spot on arm. The patient stated that the warmth and soreness started almost immediately, the induration and erythema were noted morning of the reporting day. The patient received only the adjuvant part without the powder part of the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not have diluent to provide lot number/expiry date.  Lot number/expiry date provided from SHINGRIX box.
Patient received the 2nd Moderna vaccination 21 days from the 1st vaccination. Patient is at a skilled nursing facility and will be monitored for any symptoms. Medical director has been made aware.
The patient came in to pharmacy on Oct 7, 2018 at 4:30, her left arm is red, swollen at vaccination site & says it is warm. I suggested for her to take anti-itch tablet for itch and call MD if it worsens.
Dizziness, vertigo, falling over from standing if eyes closed, hot flashes and early AM weakness. Onset a few weeks after initial Anthrax vaccination. Dizziness slowly resolved. Continued early morning weakness and hot flashes. Normal electrolytes, CBC, thyroid. Neurology consult on 11/17/98; Brain MRI.  Follow up:  Patient has not recovered from adverse event.  Patient experiences hot flashes, body temperature has low tolerance to heat.  Patient's current work duty status is full duty.  Patient has been evaluated by a physician or health care provider.  Patient did receive further shots since reported event, however no effects were taken place." The follow up received on 4/24/01 states hot flashes, body temperature has low tolerance to heat.
Approximately a month after the vaccine which was gradually oncoming, I started noticing anxiety which was getting worse, getting more stressed easily, and getting more emotional. Also, my blood sugar was higher than normal than it was before even when I wake up in the morning. This was different than before the vaccine. I use to get low numbers and now the numbers are high on my blood sugar tests. I went to my doctor and was prescribed Xanax to be taken as needed for the anxiety. My doctor also discussed the high blood sugar and I do have an future appt with the endocrinologist. I am not for sure if it is connected with the vaccine but I wanted to report because my health did change after the 3rd dose.
Her temperature is a little over 100/fever; had a fever since 2:30 PM; hives; ache; not feeling well; could not move her arm; a bit draggy; sore arm; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (could not move her arm), FEELING ABNORMAL (a bit draggy), PAIN (ache), MALAISE (not feeling well) and PYREXIA (Her temperature is a little over 100/fever) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced PAIN IN EXTREMITY (sore arm). On 21-Sep-2022, the patient experienced MOBILITY DECREASED (could not move her arm) and FEELING ABNORMAL (a bit draggy). On 22-Sep-2022, the patient experienced PAIN (ache), PYREXIA (had a fever since 2:30 PM) and URTICARIA (hives). 22-Sep-2022, the patient experienced MALAISE (not feeling well). On 22-Sep-2022 at 2:30 PM, the patient experienced PYREXIA (Her temperature is a little over 100/fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (could not move her arm), FEELING ABNORMAL (a bit draggy), PAIN (ache), MALAISE (not feeling well), PYREXIA (Her temperature is a little over 100/fever), PAIN IN EXTREMITY (sore arm), PYREXIA (had a fever since 2:30 PM) and URTICARIA (hives) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Sep-2022, Body temperature: temperature is a little over 100.         No concomitant medication information was provided. It was reported that patient previously received 3 monovalent doses. On 15-Feb-2021, the patient received first dose of Moderna covid-19 intramuscular vaccine with lot number 013L20A.  On 15-Mar-2021, the patient received second dose of Moderna covid-19 with lot number 002A21A. On 18-Nov2021, the patient received third dose of Moderna covid-19 with lot number 065F21A. It was reported that patient had high temperature around 100.   This case was linked to MOD-2022-649157 (Patient Link).
Information has been received from a physician concerning two patients who were vaccinated with a first 2.0mL PO dose of Rotateq (human bovine). Subsequently the patients developed vomiting and diarrhea. The patient's outcome was not reported. It was unknown if medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Narrative:  88 year-old patient with multiple comorbidities expired under care of hospice service after receiving COVID vaccine
2 hrs after injection pt called with chills, body aches, and feeling bad. Pt went to hospital ER. Treated 9/27/04 with Darvocet and Motrin. Pt went back to ER 9/28/04 cause feeling bad and was treated with 2 pack Rocephin. Pt called 9/29/04. She feels much better and went to work.
Itchy bright pink rash from top of shoulder down the arm, about the size of a dollar bill.  Began about one week after the shot. Was worst on day 2 of the rash. Began fading on day 3 and was almost faded on day 4 of the rash.
The patient has a history of Down's syndrome and Alzheimer's. He was brought to the ED by EMS from his adult foster care home on 3/22/23 with a fever and shortness of breath. On EMS arrival, the patient had O2 saturations of 85% on room air; this improved to 100% after the patient was placed on 10L O2 by non-rebreater. A COVID-19 rapid PCR test performed in the ED resulted positive. Ultimately the patient was admitted 3/22/23 - 3/24/23. Discharge diagnoses include end stage dementia, left lower lobe infiltrate, septic shock, and COVID-19. Of note, the patient has received the primary COVID vaccine series and three boosters.
Noticed lymph node on right side of neck enlarged approximately 4 days after vaccine. No pain just swollen and hard thought it was a cyst made appointment with my primary doctor to have it checked.
Vertigo, severe headaches, eye aches, blurry vision, extreme sensitivity to light, tingling on bottom of feet, flu-like aches, especially in shoulders and neck, dizziness, upset stomach (belch, gas, diarrhea), pixelated vision at 6-8 ft from object, vivid dreams/nightmares, extremely tired, sleeping  10-12 hours/night and napping during the day, inability to function in daily life. Cancelled trip in December. Unable to attend meeting. Convention as a participant. Unable to Chair mtg of  Action Committee.  Not able to drive, attend church, celebrate holidays w family, socialize, be a normal humam.
LOT NUMBER EXPIRED ON 10/8/2021 WITHOUT PRIOR KNOWLEDGE. VACCINE GIVEN ON 10/15/2021, NO ADVERSE REACTION NOTED.
Headache, NauseaVomiting & Tachycardia Narrative: received vaccine 2/25 evening , friday around midnight increased heart rate to 140, eyes and face swelled, nausea ,headache and lethargy remaining weekend
HISTORY OF PRESENT ILLNESS: 21 yo F p/w midsternal chest burning since 2200 last night. Acute, sharp/burning, constant, mild. No similar prior pain. Reports associated subjective dyspnea. Denies fever, chills, nausea, vomiting, syncope, palpitations, back pain, abdominal pain, weakness/numbness.   Patient states she received the J&J COVID vaccine 3 days ago, and had chills, fatigue and body aches that resolved the following day. She has since been asymptomatic.
after first covid 19 vaccine arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (after first covid 19 vaccine arm was sore) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 17-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In December 2021, the patient experienced VACCINATION SITE PAIN (after first covid 19 vaccine arm was sore). At the time of the report, VACCINATION SITE PAIN (after first covid 19 vaccine arm was sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient got her shingle shot on Monday on the same arm as her other shot. She reported experiencing fever, malaise, 'blisters' and 'redness' at the injection site, and the injection site is warm to the touch. It has gradually gotten better since then but her arm is still red.
Complained of mouth and throat numbness . Checked by EMS VSS. Cleared by EMS and NP
Excessive hair loss all over scalp. Started after 1st dose of Covid Pfizer vaccine and increased dramatically after 2nd dose. Lost ~60% of hair over the next 3 months. Hair loss stopped on month 4 after vaccine and growing back.
FEELING HOT; SWEAT; TOOTHACHE; HEART RACING; FEVER; POUNDING HEAD; TENSION IN NECK; SORENESS IN BODY; SORE ARM; FEELING ROOM ON FIRE/PARANOIA/SEEING SPIDER/POSSIBLE HALLUCINATION; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia, high blood pressure, and depression. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: unknown) dose was not reported, administered on 27-MAR-2021 on right arm for prophylactic vaccination. Concomitant medications included tramadol for fibromyalgia. On 27-MAR-2021, the patient experienced possible hallucination, tension in neck, soreness in body, sore arm and pounding head. On 28-MAR-2021, the patient experienced heart racing, toothache, fever and feeling hot and sweat. Treatment medications included: amoxicillin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from possible hallucination, paranoia, heart racing, seeing spiders, tension in neck, soreness in body, feeling hot, felt like room was on fire, sore arm, fever, and pounding head on 29-MAR-2021, and sweat, and the outcome of toothache was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210356720-COVID-19 VACCINE AD26.COV2.S-Possible hallucination. This event is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
No symptomatic AEs reported; a 4 month old received the 12 month old vaccines inadvertently for MMR-II, VARIVAX, and VAQTA; This spontaneous report was received from a nurse and refers to a 4-month-old patient of unknown gender. No information regarding the patient's medical history or concurrent conditions was provided. Concomitant medications included sterile diluent (STERILE DILUENT) (manufacturer unknown).  On 20-JUL-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA, lot #U022174, expiration date: 14-JUL-2023 (strength, dose and route of administration were not provided), hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, lot #W002889, expiration date: 06-MAR-2023 (strength, dose and route of administration were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) lot #W003819, expiration date: 02-FEB-2024 (strength, dose and route of administration were not provided), all of them for prophylaxis (Product administered to patient of inappropriate age). No adverse events were reported (No adverse event).
Pt reports what she feels is beyond the normal amount of muscle and joint pain, nausea, and vomiting. Pt also reports that she had a seizure, but that she occasionally has seizures if overtired or under stress. Pt has not received any treatment from a medical office. She has tried heating pad, OTC analgesics, and her muscle relaxer. I advised to continue otc analgesics and seek medical attention if she believes it is warrented.
Patient had redness on bilateral thighs. Skin warm to the touch. Skin felt hard. Patient started on cephalexin. Was seen and tx by pediatrician.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 68 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22May2022) Negative; (May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Did you/the patient previously receive a COVID-19 Vaccine: Yes. Reported Event: 24May2022 Had head cold symptoms after completing Paxlovid treatment and testing negative on 22May2022. Tested positive on rapid test as well.  known allergies: None  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
Information has been received from a Licensed Practical Nurse referring to a patient of unknown age and gender. Medical history and concurrent condition of the patient was not reported. On 17-NOV-2014 the patient was vaccinated with one dose of improperly stored VAQTA (lot number J015882, expiration date 22-OCT-2015, dose and route were unknown). No adverse effects reported. This is one of several reports received from same source. Additional information has been requested.
On the day after receiving the first Shingrix injection, I experienced severe pain and a red rash that began 3 inches below injection site. Rash and pain extended 6 inches down upper arm and about 3 inches across. Pain diminished after 4 days but arm still sore on sixth day. Itching was intense on day 5. Rash color faded on sixth day and itching was minimal. Overall, it felt and looked like a brief case of shingles, which I have had in the past.
Tightness of breath within first 30 minutes (subsided), itching across body (esp. shoulders, underarms, torso, palms, waist, foot) with some small bumps (1 mm) starting at 8:15pm. Still has persisted for 1 hr.  Took 50 mg of Benadryl.
About 8-10 days after the 2nd shot I?ve been knocked over by crushing fatigue and brain fog and well as transient headaches and nausea.
Local site reaction, redness, itching, back site reaction in a location of a previous shingles outbreak per patient.
a rash on the wrist; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (a rash on the wrist) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On an unknown date, the patient experienced RASH (a rash on the wrist). At the time of the report, RASH (a rash on the wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment details were reported.
arm aches, didn't seem as bad; like I had the flu for 24 hours, didn't seem as bad; This case was reported by a consumer via interactive digital media and described the occurrence of influenza in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of influenza (1st dose received on an unknown date, refer case US2022AMR120647).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza and pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the influenza and pain in arm were recovered/resolved.   It was unknown if the reporter considered the influenza and pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR120647   Additional Information: GSK Receipt Date: 16-AUG-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient never had Shingle and knock on wood. The patient opted to get the shot. It was one of if not the worst shot patient ever got. It was like patient had the flu for 24 hour and then the arm aches for a few days after that.  The second one did not seem as bad and patient guess because patient was more mentally prepared. Additional supportive information:  The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR120647:Same patient
shortness of breath, chest palpitations, chest pain, flushing, headaches, pain in RUQ abdomen and right flank, and dime-sized testicular nodule. Shortness of breath, chest palpitations, and chest pain began evening he received the Pfizer COVID-19 vaccine.  Patient has significant skepticism and anxiety about receiving the COVID-19 vaccine, which he received because it was required by employer.
TEMPORARILY ILL AFTERWARD; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced temporarily ill afterward. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from temporarily ill afterward. This report was non-serious.
Received my 3rd dose of the caving on 10/6/21. On 10/10/21 I started having issues with heart palpitations. They come and go throughout both the day and night. They often keep me up at night and make exercising difficult. I saw a physician on 11/2/21 for my normal med check and to discuss this issue. I had bloodwork and an EKG performed. The EKG showed some issues and I was put on Beta Blockers.
Sore arm that day (1/14) which is normal. Brain fog the following morning for 4 to 6 hours.
Moderate localized reaction at injection site approximately 20cm x 10cm. Erythema, warmth, induration, pain and pruritus. Associated generalized malaise and fatigue. Symptoms lasted approximately 18hours and were improved with acetaminophen and ibuprofen.
Seizure when I woke up to use the bathroom, I fell to the floor and was unconscious then regained conscious. It took about 5 minutes.
This is a 31 year-old male who had been in his usual health until 04 July 2004. He had received his primary smallpox vaccination on 06/22/2004.  He denies any prodrome of fever, chills, nausea, vomiting, diarrhea and shortness of breath. He went on leave on 02 July 2004. On July 4th while swimming he noticed a pain in his left chest 4/10 with deep breathing. He stopped swimming the pain subsided. At approximately 0200 on the 5th of July 2004 he was awakened by chest pain (8-9/10) and shortness of breath. He tried to get up out of bed and had difficulty getting out of bed secondary to the pain and shortness of breath. His parents called EMS and he was transported to the local civilian hospital. He was evaluated in the Emergency Department. He underwent an ECG, Echocardiogram, IV fluid hydration and  IV morphine sulfate. He was then admitted to cardiology/telemetry floor.  He was monitored and treated until his discharge on 09 July 2004. He was placed on sick in quarters until 13 July 2004. He returned to on Motrin, colchine and no pain medication. On the 13th the pain returned to his left chest area (5/10) and was short of breath with exertion. On 14th of July his chest pain increased to 7/10 and shortness of breath due to increased pain. He stated that chest pain decreases when he leans forward and increases in supine position. He was seen by a cardiologist and diagnosed with on-going pericarditis in temporal association with receipt of primary smallpox vaccination.